World’s first one wrist ecg band and other revolutionary products from Europe’s fastest growing biotech company in $142b market investment opportunity with 28x return in 3 years
Hypertension management will change more in the next 5 years than in the last...Valencell, Inc
Why will managing hypertension change more in the next 5 years than it has in the last 100?
There are several macro trends that are driving this change:
- Hypertension is a massive global health problem (over 1B people have high BP) and it is THE leading risk factor for the global burden of disease (its a comorbidity in every major chronic disease) - more of a risk factor than tobacco, obesity, poor diet, high blood glucose, etc. - according to the WHO.
- Sensor tech - there has been no meaningful innovation in BP sensors in over 100 years. The BP cuffs in use today are fundamentally the same as the first BP cuff that came to market in the early 1900's. That’s changing now with cuffless BP sensors that are being approved by regulatory bodies.
- Care delivery – healthcare "has left the building", moving out of the hospital, into the home and everyday life. This can be seen in the huge growth in remote patient monitoring, digital therapeutics, and digital health more broadly.
- Payer models – insurance coverage is moving from fee-for-service to value-based care that’s focused on prevention and monitoring. This is particularly important in hypertension management because high BP has no outward symptoms, making the frequency and ease of BP monitoring extremely important.
Best practices in using wearable biometric sensors to prove medical use casesValencell, Inc
The use of wearable devices in health and medical use cases is growing rapidly along with the number and capabilities of wearable devices. The sensor technology embedded in wearables today rivals the capabilities of regulatory-approved medical devices, and in many cases enables new and different use cases than we’ve seen possible before. This session will highlight the best practices we’ve seen emerging recently from real-world projects proving the efficacy of wearable devices in health and medical use cases in the areas of cardiovascular conditions, neurological disease, pain management, and other areas of interest. We’ll also explore the potential pitfalls to avoid and key things to consider when using wearables in proving out your medical use case.
Utilizing wearable technology in remote patient monitoring with aging populat...Valencell, Inc
Most developed nations are experiencing a dramatic aging of the population, which is putting pressure our healthcare systems to provide care outside of medical facilities and driving opportunities for remote patient monitoring systems. In fact, 90% of family caregivers want a way to monitor their loved ones, receive alerts and be involved in their care. This webinar will discuss the trends driving remote patient monitoring today and how these systems are utilizing wearable technology to elevate the level of care possible outside of medical facilities. You won’t want to miss this webinar!
Webinar: Calibration-free blood pressure monitoring using biometric earbudsValencell, Inc
Valencell was scheduled to present the results of a clinical study on its groundbreaking blood pressure monitoring technology at the American College of Cardiology conference in March, but unfortunately that conference was cancelled. So we’ve decided to share that presentation and research here in a webinar format with an open Q&A session. You can find more information on Valencell's blood pressure technology here: https://valencell.com/bloodpressure/
Blood pressure market research study - November 2020Valencell, Inc
In November 2020, Valencell conducted a research study on people with hypertension to understand the personal impact of managing the disease every day and the potential for digital health solutions to improve hypertension management.
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)KickstartPH
Kickstart Ventures' 2nd HealthTech Forum featured Julien de Salaberry, a globally-recognised expert on healthcare and technology.
Julien, the Chief Innovation Officer and Founder of The Propell Group (based in Singapore), talked about healthcare trends in Southeast Asia and how “frugal innovation" can be done in healthcare delivery.
And yeah, if you've got an interesting healthtech startup, message us at info@kickstart.ph. #startupPH
X Sector Disruption | CIO Leaders Summit 2015 | The Propell GroupJulien de Salaberry
- Technology is or will disrupt your sector
- Hoping that it might miss you out is not a strategy!
- You will need to embrace and adopt the technology to innovate to stay in the game
- You also have the opportunity to explore how technology could enable your industry to disrupt another
Hypertension management will change more in the next 5 years than in the last...Valencell, Inc
Why will managing hypertension change more in the next 5 years than it has in the last 100?
There are several macro trends that are driving this change:
- Hypertension is a massive global health problem (over 1B people have high BP) and it is THE leading risk factor for the global burden of disease (its a comorbidity in every major chronic disease) - more of a risk factor than tobacco, obesity, poor diet, high blood glucose, etc. - according to the WHO.
- Sensor tech - there has been no meaningful innovation in BP sensors in over 100 years. The BP cuffs in use today are fundamentally the same as the first BP cuff that came to market in the early 1900's. That’s changing now with cuffless BP sensors that are being approved by regulatory bodies.
- Care delivery – healthcare "has left the building", moving out of the hospital, into the home and everyday life. This can be seen in the huge growth in remote patient monitoring, digital therapeutics, and digital health more broadly.
- Payer models – insurance coverage is moving from fee-for-service to value-based care that’s focused on prevention and monitoring. This is particularly important in hypertension management because high BP has no outward symptoms, making the frequency and ease of BP monitoring extremely important.
Best practices in using wearable biometric sensors to prove medical use casesValencell, Inc
The use of wearable devices in health and medical use cases is growing rapidly along with the number and capabilities of wearable devices. The sensor technology embedded in wearables today rivals the capabilities of regulatory-approved medical devices, and in many cases enables new and different use cases than we’ve seen possible before. This session will highlight the best practices we’ve seen emerging recently from real-world projects proving the efficacy of wearable devices in health and medical use cases in the areas of cardiovascular conditions, neurological disease, pain management, and other areas of interest. We’ll also explore the potential pitfalls to avoid and key things to consider when using wearables in proving out your medical use case.
Utilizing wearable technology in remote patient monitoring with aging populat...Valencell, Inc
Most developed nations are experiencing a dramatic aging of the population, which is putting pressure our healthcare systems to provide care outside of medical facilities and driving opportunities for remote patient monitoring systems. In fact, 90% of family caregivers want a way to monitor their loved ones, receive alerts and be involved in their care. This webinar will discuss the trends driving remote patient monitoring today and how these systems are utilizing wearable technology to elevate the level of care possible outside of medical facilities. You won’t want to miss this webinar!
Webinar: Calibration-free blood pressure monitoring using biometric earbudsValencell, Inc
Valencell was scheduled to present the results of a clinical study on its groundbreaking blood pressure monitoring technology at the American College of Cardiology conference in March, but unfortunately that conference was cancelled. So we’ve decided to share that presentation and research here in a webinar format with an open Q&A session. You can find more information on Valencell's blood pressure technology here: https://valencell.com/bloodpressure/
Blood pressure market research study - November 2020Valencell, Inc
In November 2020, Valencell conducted a research study on people with hypertension to understand the personal impact of managing the disease every day and the potential for digital health solutions to improve hypertension management.
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)KickstartPH
Kickstart Ventures' 2nd HealthTech Forum featured Julien de Salaberry, a globally-recognised expert on healthcare and technology.
Julien, the Chief Innovation Officer and Founder of The Propell Group (based in Singapore), talked about healthcare trends in Southeast Asia and how “frugal innovation" can be done in healthcare delivery.
And yeah, if you've got an interesting healthtech startup, message us at info@kickstart.ph. #startupPH
X Sector Disruption | CIO Leaders Summit 2015 | The Propell GroupJulien de Salaberry
- Technology is or will disrupt your sector
- Hoping that it might miss you out is not a strategy!
- You will need to embrace and adopt the technology to innovate to stay in the game
- You also have the opportunity to explore how technology could enable your industry to disrupt another
Expanding hearables and next generation hearing health: A conversation with S...Valencell, Inc
Consumers have come to expect more from their wearable devices and as the markets for hearables and hearing health devices continue to grow, biometrics have become essential. In this webinar, Sonion, the global leader in micro-acoustic technologies for hearing instruments, joins us to explore the benefits of biometric sensors in the ear.
Hamidreza Taghavi, Senior Product Manager at Sonion, discusses the ongoing convergence between the consumer wearables/hearables market and health and medical devices and where this technology is headed, particularly as hearing aids get smarter and hearables gain more capabilities.
Presentation given at the Garage Start Digital Health Startup Workshop sponsored by ABRT Venture Capital. Content focuses on the healthtech investment landscape.
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
State of Wearables Today - 2018 Consumer SurveyValencell, Inc
A new national survey released today on wearables revealed that actionable, accurate health insights from wearables will be increasingly important to the success of the industry and 63% of respondents have owned a wearable device at some point, up from 42% in 2016. The online survey polled 826 consumers from a wide range of U.S. regions, ages, and income levels on their experiences and preferences around wearables. The 2018 survey is a follow-up from the same survey conducted by Valencell in 2016.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
A recent national survey on wearable technology devices (“wearables”) revealed that consumers consider accuracy the most important feature of wearables, and more than half of those who do not own a wearable would consider buying one if they trusted the accuracy. Among those surveyed, more than 42% of respondents own or have owned a wearable device, and the majority (63%) ranked accuracy as a highly important feature of that wearable. Among wearable owners, 80% feel that their wearable has a positive impact on their health. For those who do not own a wearable, 74% of would consider using one if accuracy in wearables could help them to better manage their health.
Is it self-tracking? We are only beginning to understand the power of self-tracking be it due to the quantified self movement or because of the increasing number of connected medical devices. A real opportunity is in understanding how mobile devices will play a key role in the future of our personal health. Medical Devices, sensors, big data, cloud computing are and will continue to enable continuous monitoring of people and patients.
Top Wearables Predictions for the Year Ahead and 2018: Year in ReviewValencell, Inc
Where is wearable technology heading and what can we expect from the wearables market? When it comes to biometric wearables and hearables, we've only scratched the surface of what's possible. In this webinar, Dr. Steven LeBoeuf takes a look back at trends and achievements in wearables in 2018 and weighs in on the outcomes of last year's predictions. We also highlight some unexpected changes you need to be ready for in 2019 and beyond.
Wearables in Healthcare: 2016 Prospects and the Money-Saving PatientEspeo Software
2016 looks to be a disruptive year for healthcare-focused wearables, especially those focused on preventive care or the management of chronic illnesses. This also translates into serious savings for the consumer... and profit for a wearable tech business.
This report makes available Remote Monitoring Solutions presented by 71 companies who replied to the Hospital Bernal Solution Match Call, launched by eHealth HUB in February 2017.
Healthcare AI will undoubtedly become one of the fastest growing industries in the industry. Although the medical and health artificial intelligence industry was valued at US$ 600 million in 2014 , it is expected to reach a staggering US$ 150 billion by 2026. There are countless AI applications in the healthcare industry, let’s look at some outstanding ones.
Digital Therapeutics / Digital Health Innovation Rawane Jabara
Ampersand & Ampersand is a digital health and therapeutics agency based in London. We specialise in co-developing clinically relevant software that puts patients at the heart of their health management. "Digital therapeutics represent a new generation of healthcare that uses innovative, clinically-validated disease management and direct treatment applications to enhance, and in some cases replace, current medical practices and treatments." - Digital Therapeutics Alliance. Check out our work here and get in touch. 3amp.com rawane@3amp.com
Expanding hearables and next generation hearing health: A conversation with S...Valencell, Inc
Consumers have come to expect more from their wearable devices and as the markets for hearables and hearing health devices continue to grow, biometrics have become essential. In this webinar, Sonion, the global leader in micro-acoustic technologies for hearing instruments, joins us to explore the benefits of biometric sensors in the ear.
Hamidreza Taghavi, Senior Product Manager at Sonion, discusses the ongoing convergence between the consumer wearables/hearables market and health and medical devices and where this technology is headed, particularly as hearing aids get smarter and hearables gain more capabilities.
Presentation given at the Garage Start Digital Health Startup Workshop sponsored by ABRT Venture Capital. Content focuses on the healthtech investment landscape.
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
State of Wearables Today - 2018 Consumer SurveyValencell, Inc
A new national survey released today on wearables revealed that actionable, accurate health insights from wearables will be increasingly important to the success of the industry and 63% of respondents have owned a wearable device at some point, up from 42% in 2016. The online survey polled 826 consumers from a wide range of U.S. regions, ages, and income levels on their experiences and preferences around wearables. The 2018 survey is a follow-up from the same survey conducted by Valencell in 2016.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
A recent national survey on wearable technology devices (“wearables”) revealed that consumers consider accuracy the most important feature of wearables, and more than half of those who do not own a wearable would consider buying one if they trusted the accuracy. Among those surveyed, more than 42% of respondents own or have owned a wearable device, and the majority (63%) ranked accuracy as a highly important feature of that wearable. Among wearable owners, 80% feel that their wearable has a positive impact on their health. For those who do not own a wearable, 74% of would consider using one if accuracy in wearables could help them to better manage their health.
Is it self-tracking? We are only beginning to understand the power of self-tracking be it due to the quantified self movement or because of the increasing number of connected medical devices. A real opportunity is in understanding how mobile devices will play a key role in the future of our personal health. Medical Devices, sensors, big data, cloud computing are and will continue to enable continuous monitoring of people and patients.
Top Wearables Predictions for the Year Ahead and 2018: Year in ReviewValencell, Inc
Where is wearable technology heading and what can we expect from the wearables market? When it comes to biometric wearables and hearables, we've only scratched the surface of what's possible. In this webinar, Dr. Steven LeBoeuf takes a look back at trends and achievements in wearables in 2018 and weighs in on the outcomes of last year's predictions. We also highlight some unexpected changes you need to be ready for in 2019 and beyond.
Wearables in Healthcare: 2016 Prospects and the Money-Saving PatientEspeo Software
2016 looks to be a disruptive year for healthcare-focused wearables, especially those focused on preventive care or the management of chronic illnesses. This also translates into serious savings for the consumer... and profit for a wearable tech business.
This report makes available Remote Monitoring Solutions presented by 71 companies who replied to the Hospital Bernal Solution Match Call, launched by eHealth HUB in February 2017.
Healthcare AI will undoubtedly become one of the fastest growing industries in the industry. Although the medical and health artificial intelligence industry was valued at US$ 600 million in 2014 , it is expected to reach a staggering US$ 150 billion by 2026. There are countless AI applications in the healthcare industry, let’s look at some outstanding ones.
Digital Therapeutics / Digital Health Innovation Rawane Jabara
Ampersand & Ampersand is a digital health and therapeutics agency based in London. We specialise in co-developing clinically relevant software that puts patients at the heart of their health management. "Digital therapeutics represent a new generation of healthcare that uses innovative, clinically-validated disease management and direct treatment applications to enhance, and in some cases replace, current medical practices and treatments." - Digital Therapeutics Alliance. Check out our work here and get in touch. 3amp.com rawane@3amp.com
Cardiac Holter Monitor Market PPT: Demand, Trends and Business Opportunities ...IMARC Group
According to the latest report by IMARC Group, the global cardiac Holter monitor market reached a value of US$ 386 Million in 2020.
A cardiac Holter monitor is a battery-operated portable electrocardiography (ECG) device that records the heart rhythm continuously for around 24 to 48 hours.
It consists of a monitor, software and electrodes, which aid in interpreting the recorded data, determining if the heart is getting adequate oxygen and diagnosing conditions concerning irregular cardiac rhythms, such as tachycardia, arrhythmia and atrial fibrillation.
April 2013 StartUp Health Insights Funding ReportStartUp Health
See StartUp Health Insights (http://www.startuphealth.com/insights) for the most comprehensive digital health funding database. Apply to StartUp Health Academy here: http://www.startuphealth.com/about-us/application/
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Medical equipment manufacturing business plan exampleupmetrics.co
If you are planning to start a new manufacturing business, the first thing you will need is a business plan. Use our Lanzor - medical equipment manufacturing business plan example created using upmetrics business plan software to start writing your business plan in no time.
Before you start writing your business plan for your new medical equipment manufacturing business, spend as much time as you can reading through some examples of manufacturing business plans. Reading some sample business plans will give you a good idea of what you’re aiming for and also it will show you the different sections that different entrepreneurs include and the language they use to write about themselves and their business plans.
We have created this medical equipment manufacturing business plan example for you to get a good idea about how a perfect manufacturing business plan should look like and what details you will need to include in your stunning business plan.
Day one conference projects with journey mapsDayOne
DayOne Conference 2019 projects and journey maps. 30 ventures presented their solutions and together with conference participants built a journey map of their future.
Convergence of medicines and consumer productsMichael Frank
Consumer products and medicines are becoming increasingly convergent. Innovation from the laboratory are accelerating into consumer technology, and vice versa.
Business Plan for NerveShield, a wearable ultrasonic device to relieve diabet...MalavikaSankararaman
Introduction and business plan of NerveShield, a wearable ultrasonic device to relieve diabetic patients from neuropathy pain, into the European Market.
Qrepublik MedID Presentation Product (NEW)_compressed.pdfQREPUBLIC, INC.
QRepublik Medical ID is a beautifully designed medical ID platform built exclusively for people. We make it easy to medical IDs to thousands of people in the United States and around the world. In emergencies or times of need, we provide members’ critical health and identification information to first responders. This information exchange empowers first responders to act promptly to protect and save lives.
Solutions for B2B &B2C market
Diagnos Inc. Investor Presentation September 2018MomentumPR
Diagnos is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of its artificial intelligence tool CARA (computer-assisted retina analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA is a cost-effective tool for screening large numbers of patients in real time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration and the European Union.
LEARN MORE ABOUT INVESTOR OPPORTUNITIES HERE: https://vivaquant.sppx.io/
We all know someone who has had a heart attack or other cardiac condition. And despite significant therapeutic and diagnostics advancements, heart disease and cardiac events remain the leading causes of death in both men and women in the United States and cost more than $200 billion in health care services annually. Earlier and more accurate arrhythmia diagnosis can help change that, but we need your help!
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
JMeter webinar - integration with InfluxDB and GrafanaRTTS
Watch this recorded webinar about real-time monitoring of application performance. See how to integrate Apache JMeter, the open-source leader in performance testing, with InfluxDB, the open-source time-series database, and Grafana, the open-source analytics and visualization application.
In this webinar, we will review the benefits of leveraging InfluxDB and Grafana when executing load tests and demonstrate how these tools are used to visualize performance metrics.
Length: 30 minutes
Session Overview
-------------------------------------------
During this webinar, we will cover the following topics while demonstrating the integrations of JMeter, InfluxDB and Grafana:
- What out-of-the-box solutions are available for real-time monitoring JMeter tests?
- What are the benefits of integrating InfluxDB and Grafana into the load testing stack?
- Which features are provided by Grafana?
- Demonstration of InfluxDB and Grafana using a practice web application
To view the webinar recording, go to:
https://www.rttsweb.com/jmeter-integration-webinar
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
WORLD’S FIRST ONE WRIST ECG BAND
1. WORLD’S FIRST
ONE WRIST ECG BAND
IN $142B MARKET INVESTMENT OPPORTUNITY
WITH 28X RETURN IN 3 YEARS
AND OTHER REVOLUTIONARY PRODUCTS FROM EUROPE’S FASTEST GROWING BIOTECH COMPANY
2. POWER PITCH
Planexta addressing the group of healthcare markets
that will hit
$142 Billions by 2020
with unique and highly demanded technologies:
World’s first one-wrist ECG band
Instrumental Online Diagnostics
CardioCloud Service
Endovenous Electric Welding
Planexta solutions are easily scalable, bring instant revenue, have numerous revenue streams.
3. World’s first one-wrist ECG band
and 5-product lineup of specialised
bands on its base
Endovenous Electric Welding technology
CardioCloud
Data Analysis Service
Health & Fitness Wearables
3,8B market by 2020, CAGR 20%
Connected Healthcare
117B market by 2020 (Forbes), CAGR 36%
Endovenous Vascular Surgery
(Potential 29B market by 2020)
Instrumental Online Diagnostics
Telemedicine Consulting Service
Planexta Technologies Markets
Electronic Health Records
(21B market by 2020, CAGR 43%)
MARKET OPPORTUNITY
4. WHY WE WILL SUCCEED
Team
driven by very successful entrepreneurs
and prominent medical professionals
Own R&D lab
enables us to deliver super-fast results
Contract for 5 million units/month
in sales till the end of 2016 with market access
company that has strong and relevant track record
Extensive experience
in bringing products to European,
North American and Canadian markets
8 products in pipeline,
6 of them for both consumer and enterprise markets
Way ahead of the competition
Launching with industry’s best offers
Own fund
to attract large scale projects, such as United
Nations cardio-screening programs
Extremely high demand:
pre-order for 50.000 wristband units from largest
CIS electronics dealer. Signed a number
of partnership agreements with world’s leading
health companies and organisations
5. BUSINESS MODEL
Revenue sources: Customer acquisition:
ECG Wristbands
Instrumental Online Diagnostics
CardioCloud Service
Endovenous Electro-welding
‣ Online & offline retail distributors
‣ White-label
‣ Publicity, networking and event participation
‣ Partnerships with telemedicine companies, healthcare organisations and funds
‣ Partnerships with insurance companies
‣ Partnerships with medical companies, organisations and funds
‣ Agreements with national and international healthcare funds and organisations‣ White-label
‣ Partnerships with medical and healthcare companies, organisations and funds
‣ Subscriptions (consumers)
‣ White-label
‣ Insurance companies
‣ Subscriptions (doctors)
‣ Subscriptions (medical companies)
‣ White-label
‣ Market access companies
‣ Market access companies
6. INVESTMENT
We need:
3,5M for 25% of equity.
How we will spend it:
‣ 1,2M for R&D Impulse Lab that will quadruple our
effectiveness
‣ 300K for BizDev and Market Access dept., financial
and legal services
‣ 1,75M to finalise development of the wristbands lineup
‣ 250K to launch in US and Canada
We propose:
‣ Clear exit strategy
‣ Clear 5 year P&L plan
‣ IPR capitalisation
7. VISION
HRV (Heart Rate Variability) analysis
is an established method of monitoring for various health parameters: cardiovascular, respiratory, muscular, nervous
and glandular systems, emotional state, immunity factors, stress, circadian rhythm, signs of ageing, etc. It might even
save your life by alerting about upcoming heart attack.
But in order to make accurate conclusions the measuring must be extremely precise and performed on a regular
basis. That was limiting its usage to clinical environment.
Its benefits in full were available only to astronauts and pro-athletes.
We are bringing it to consumer market
9. Planexta Inc. created
world’s first one-wrist ECG band
that performs HRV analysis with the same accuracy as hospital grade
electrocardiograph. It measures >80 health parameters and helps you to get
yourself into peak health state, both physical and mental.
Live long (+5 years on average) and prosper!
VISION
10. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
World’s first one-wrist ECG band
Planexta ECG wristbands
advantages
Unique technology, no direct competitor.
We succeeded where many better funded companies was unable to deliver so far. Including Google.
Helps you to get yourself into peak health state, both physical and mental.
It could even alert about conditions that have not yet manifested themselves,
including upcoming heart stroke.
11. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
Planexta Active
World’s first one-wrist ECG band
Live to the max!
Status: prototype is ready. US patent pending.
Working on design with STUCK, one of world’s top industrial design studios.
1st product lot TBD September 2016. Launch is planned for January 2017 at CES
12. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
Planexta Sport
Waterproof one-wrist ECG band + sports apps.
Train to the max!
Status: under development. 1st lot TBD September 2016.
13. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
Planexta Care
Medical diagnostic instrument
Status: under development. 1st lot TBD September 2016.
14. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
Planexta Care Pro
3-channel ECG + blood pressure sensor
connected to medical infrastructure
Status: under development. 1st lot TBD September 2016.
15. PRODUCTS: PLANEXTA ECG WRISTBAND LINEUP
Planexta Home Care
6-channel wireless cardiograph for dynamic
monitoring at home. 15% more accurate
than any competitors product.
Status: under development. 1st lot TBD September 2016.
16. PLANEXTA ECG WRISTBAND LINEUP: REVENUE MODEL
Customers:
‣ Consumers
‣ Health, fitness and medical companies
‣ Corporate wellness sector
‣ Healthcare funds and organisations
How do we make money: 30% profit margin of wristbands price (starts at $299) +
$60 annual subscription fee for specialised apps.
Lifetime value of average customer: $1266
17. PLANEXTA ECG WRISTBAND LINEUP: TRACTION
▸ Secured 50.000 SKU order from largest CIS electronics dealer
▸ Partnered with:
Beyond Nature Inc., market access company that made #7 most successful
product launch in category
Global Health Resolution Finance
Global Medic
▸ Huge interest from medical companies from all over the world
18. Alternative options have very limited application:
FitPal patch (not yet available) requires sticking it to the
chest or stomach and positioned solely as a fitness gear.
AliveCor wristband for Apple Watch (awaiting FDA
approval) requires pressing finger in order to receive data,
so no continuous monitoring.
BioPac doesn’t make consumer devices.
All the rest (Samsung, Fitbit, etc.) measure not the electric
impulses but simply pulse, which does not provide
comparable data and precision.
PLANEXTA ECG WRISTBAND LINEUP: COMPETITORS
19. PLANEXTA ECG WRISTBAND LINEUP: MARKETING AND GROWTH STRATEGY
Planexta enters the market with the absolute best solutions in every sector.
We are going to win all relevant contests and competitions and get massive
publicity: CES Awards, RedDot Award, MedTech Award, etc.
Besides traditional marketing channels we are working on cooperation with
international healthcare organisations to solve the socially significant tasks.
20. PLANEXTA ECG WRISTBAND LINEUP: FINANCIALS
Pessimistic scenario
▸ Total customers: 691.800
▸ Total revenue: $208M
▸ Total expense: $114M
▸ EBITDA: $106M
Expected results:
In 1 year the volume of sales will reach 5M/month.
Next year we plan to double sales due to US market expansion
and launches in Europe, India and China.
Realistic scenario
▸ Total customers: 922.400
▸ Total revenue: $277M
▸ Total expense: $152M
▸ EBITDA: $141,6M
Optimistic scenario (excluding
white-label and licensing strategy)
▸ Total customers: 1.153.000
▸ Total revenue: $346M
▸ Total expense: $190M
▸ EBITDA: $177M
3 years projection:
21. No more “How do you feel today?” questions.
The doctor knows best
Planexta Instrumental Online
Diagnostics advantages
Planexta ECG wristband measures 68 health parameters with the same accuracy as hospital
grade electrocardiograph. Combined with telemedicine service, it enables doctor to monitor
patient’s health status remotely on a whole new level.
PRODUCTS: PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS
22. PRODUCTS: PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS
— So how am I doing,
Doctor?
— I see your pain level decreased 42%
and your stress index is 75% better!
Status: under development
23. PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS: REVENUE MODEL
Customers: telemedicine companies
How do we make money: 30% profit margin of wristband price (starts at $299) +
5% of consultation cost ($2,5 per consultation).
Lifetime value of average customer: $1266
24. PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS: COMPETITORS
Currently available options:
there are plenty of them.
But our solution takes the whole industry to the next level:
‣ It is wearable, this opens the opportunity of dynamic long-therm monitoring
and possibility to focus on prevention
‣ Delivers more complete analysis
‣ Has added benefit of continuous blood pressure measurement
25. PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS: MARKETING AND GROWTH STRATEGY
‣ Territorial business development with gradual market penetration.
‣ Direct sales to doctors.
‣ Partnership programs with medical service providers
and insurance companies.
26. PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS: TRACTION
Partnered with:
‣ Global Health Resolution Finance
‣ Global Medic
‣ OVB Insurance Group
27. PLANEXTA INSTRUMENTAL ONLINE DIAGNOSTICS: FINANCIALS
Realistic scenario
▸ Total customers: 18500
▸ Total revenue: $23,5M
▸ Total expense: $3,85M
▸ EBITDA: $19,65M
3 years projection:
28. Making doctors 7X more effective.
While saving them a ton of money
Planexta CardioCloud
advantages
There are no cloud solutions on the market.
Currently clinics and doctors are buying
conventional stationary cardiographs
for $6000-7000K that analyse data
with a built-in hardware.
We offer them tiny mobile cardiographs
for $199 that deliver even more precise
and much more comprehensive analysis
thanks to our CardioCloud service solution.
PRODUCTS: PLANEXTA CARDIOCLOUD
30. PLANEXTA CARDIOCLOUD: REVENUE MODEL
Customers: doctors, hospitals, clinics, healthcare organisations.
How do we make money: $50 monthly fee + optional mobile electrocardiograph
for $199.
Lifetime value of average customer: $12000
31. PLANEXTA CARDIOCLOUD: TRACTION
We already have a long queue of companies awaiting for this
service with a total commitment for more than $1M (with a cost
of sale <10%).
Partnered with:
‣ Global Health Resolution Finance
‣ Assmus Capital
32. PLANEXTA CARDIOCLOUD: COMPETITORS
Currently available solutions:
Biopac and other third-party software (Kubios, Corscience) are oriented on
research, not business needs.
Other comparable options are pricey ($5000-$6000) and all have III-generation
analytics capabilities, while we offer IV-generation (nosological & pre-nosological)
diagnostics with 580 parameters.
34. Now the surgeon knows exactly what he’s doing
Planexta Endovenous
Electric Welding technology
Unlike it’s EVLA and RFA counterparts, electro-welding technology provides biofeedback
during operation. And it’s extremely valuable for surgeons since they can monitor
intensity of their intervention.
30% Therapeutic Index increase. Greatly reduces operative and post-operative risks.
PRODUCTS: PLANEXTA ENDOVENOUS ELECTRIC WELDING
35. PRODUCTS: PLANEXTA ENDOVENOUS ELECTRIC WELDING
Status: working prototype already in use. Patent pending.
https://youtu.be/tRNXsRLIEQk
Warning: explicit content
36. Endovenous laser surgery and RF ablation market size is 200M.
And we are aiming to own 30% of it in 5 years.
But the market for procedure itself is 100X bigger.
This means huge potential for investment activity
PLANEXTA ENDOVENOUS ELECTRIC WELDING: INVESTMENT OPPORTUNITY
37. Problem
Currently clinics pay on average $30.000 for a laser device.
Solution
We offer them much more cost-effective, “no-threshold" option: to lease an entire
“turn-key” solution and pay only a small percentage from every procedure cost.
Planexta covers all aspects: technology, installation and doctor training.
Way to markets
Partnering with specialised medical companies that run medical device leasing business
in US and Europe. For 60% of the cost of sales they will cover all necessary researches,
regulatory procedures, manufacture and marketing.
PLANEXTA ENDOVENOUS ELECTRIC WELDING: INVESTMENT OPPORTUNITY
38. PLANEXTA ENDOVENOUS ELECTRIC WELDING: REVENUE MODEL
Customers: doctors, clinics, hospitals.
How do we make money: 5% of procedure cost ($400-$2000)
Pricing: $20 on average
Lifetime value of average customer: $480.000
39. PLANEXTA ENDOVENOUS ELECTRIC WELDING: TRACTION
Partnered with:
‣ Global Health Resolution Finance Services
‣ Ozone Investment
40. PLANEXTA ENDOVENOUS ELECTRIC WELDING: MARKETING AND GROWTH STRATEGY
‣ Territorial business development with gradual market penetration.
‣ Direct sales to doctors, clinics, hospitals.
‣ Partnership programs with medical service providers
and insurance companies.
41. PLANEXTA ENDOVENOUS ELECTRIC WELDING: FINANCIALS
Realistic scenario
▸ Total customers: 2000
▸ Total revenue: $60M
▸ Total expense: $50%
▸ EBITDA: $30M
3 years projection:
42. TEAM
Healthcare expertise:
Novartis, Genzyme, Merck Sharp & Dohme, Pfizer
Entrepreneurial expertise:
Vector, pharmaceutical market access and development company that holds records in fast tracking
national programs development for The World Bank, European Commission, Genzyme, MSD, Pfizer.
MGID.com, first native advertising marketplace ($30M annual turnover)
MedIT expertise:
MAYO Clinic, John Hopkins University Clinic, Mount Sinai Hospital
Scientific expertise:
microelectronics, system analysis, math methods, medical devices, sensor networks, social technologies
43. TEAM
CEO
Eugeny Nayshtetik, MIB, MM, MSOC, President Planexta Inc.
12 years of successful entrepreneurial experience in the field of life sciences.
14 years on top positions in Pfizer, Merck, Genzyme, Sanofi, Novartis.
A great number of achievements in medical market access sphere, including:
‣ The most fast tracking regional program development in Ukraine with further
inclusion into municipal budget for Genzyme
‣ The fastest market access with inclusion into national HIV program for Merck
Extensive experience in health technology assessment and objectivisation of
pharmacoeconomics data on implementation of medical technologies.
International Business and Marketing Management graduate.
PhD candidate in Social Technologies.
44. TEAM
R&D Leader
Tetiana Botsva
Unique experience with medical information technologies and medical
software development. Deep knowledge in standardisation of medical
technologies and business analysis.
9 years of hardware & software development experience in life sciences field.
Successful projects for MAYO clinic, John Hopkins University Clinic, Mount
Sinai Hospital and number of clinics in Alaska (USA)
SoftComputer Consultants (USA) in the background.
Physics, electronics and computer Systems graduate, PhD candidate
45. FINANCIALS: TOTAL FOR PLANEXTA INC.
Realistic scenario
▸ Total revenue: $570,5M
▸ EBITDA: $359,25M
Optimistic scenario (excluding
white-label and licensing strategy)
▸ Total revenue: $639,5M
▸ EBITDA: $394,6M
3 years projection:
Pessimistic scenario
▸ Total revenue: $501,5M
▸ EBITDA: $323,6M
46. FINANCIALS: TOTAL FOR PLANEXTA INC.
3 years growth projection:
0
22.5
45
67.5
90
1Q ‘17 2Q ‘17 3Q ‘17 4Q ‘17 1Q '18 2Q '18 3Q '18 4Q ‘18 1Q '19 2Q ‘19 3Q '19 4Q '19
EBITDA, Millions